Doxorubicin hydrochloride and Xeloda drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Doxorubicin hydrochloride (doxorubicin hydrochloride) and Xeloda (capecitabine). Common drug interactions include diarrhoea among females and cardiac failure among males.
The phase IV clinical study analyzes what interactions people have when they take Doxorubicin hydrochloride and Xeloda. It is created by eHealthMe based on reports of 191 people who take the same drugs from the FDA, and is updated regularly.
What is Doxorubicin hydrochloride?
Doxorubicin hydrochloride has active ingredients of doxorubicin hydrochloride. eHealthMe is studying from 25,343 Doxorubicin hydrochloride users. Check the latest studies of Doxorubicin hydrochloride.
What is Xeloda?
Xeloda has active ingredients of capecitabine. It is often used in colon cancer. eHealthMe is studying from 46,649 Xeloda users. Check the latest studies of Xeloda.
191 people who take Doxorubicin hydrochloride and Xeloda together, and have interactions are studied.
What are the common drug interactions of Doxorubicin hydrochloride and Xeloda, by gender? *
What are the common drug interactions of Doxorubicin hydrochloride and Xeloda, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Doxorubicin hydrochloride and Xeloda?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Doxorubicin hydrochloride (25,343 reports)
- Xeloda (46,649 reports)
Browse all drug interactions of Doxorubicin hydrochloride and Xeloda:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Doxorubicin hydrochloride:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Xeloda:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Doxorubicin hydrochloride and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Xeloda and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Pinto HP, Bhat RM, Shet D, Dandekeri S, "Compound mucocutaneous adverse effects of oral capecitabine in a patient", Indian dermatology online journal, 2014 Jan .
- Kang SM, Baek JY, Hwangbo B, Kim HY, Lee GK, Lee HS, "A case of capecitabine-induced sarcoidosis", Tuberculosis and respiratory diseases, 2012 Mar .
- Pinto HP, Bhat RM, Shet D, Dandekeri S, "Compound mucocutaneous adverse effects of oral capecitabine in a patient", Indian dermatology online journal, 2014 Jan .
- Kang SM, Baek JY, Hwangbo B, Kim HY, Lee GK, Lee HS, "A case of capecitabine-induced sarcoidosis", Tuberculosis and respiratory diseases, 2012 Mar .
How the study uses the data?
The study uses data from the FDA. It is based on doxorubicin hydrochloride and capecitabine (the active ingredients of Doxorubicin hydrochloride and Xeloda, respectively), and Doxorubicin hydrochloride and Xeloda (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Cartia Xt cause Hypothyroidism? - 29 seconds ago
- Could Mupirocin cause Faecal Incontinence? - 47 seconds ago
- Drug interactions of Melphalan Hydrochloride and Oramorph Sr - a minute ago
- Could Quinine Sulfate cause Ventricular Hypertrophy? - a minute ago
- Drug interactions of Melatonin and Lactobacillus Reuteri - a minute ago
- Drug interactions of Megace and Arthrotec - a minute ago
- Atacand Hct vs. Klor-Con M10, side effect and effectiveness comparison - a minute ago
- Drug interactions of Metoclopramide Hcl and Nasonex - a minute ago
- Could Sulfamethoxazole cause Deep Vein Thrombosis Postoperative? - a minute ago
- Drug interactions of Prozac and Valsartan - a minute ago